Search Result "Autosomal Dominant Hypercholesterolemia(ADH)."
Autosomal Dominant Hypercholesterolemia: Needs for Early Diagnosis and Cascade Screening in the Tunisian Population
Journal: Current Genomics
Volume: 14 Issue: 1 Year: 2013 Page: 25-32
Author(s): Awatef Jelassi,Mohamed Najah,Afef Slimani,Imen Jguirim,Mohamed Naceur Slimane,Mathilde Varret
PC9, A New Actor in Autosomal Dominant Hypercholesterolemia
Journal: Current Genomics
Volume: 6 Issue: 7 Year: 2005 Page: 535-543
Author(s): Delphine Allard, Marianne Abifadel, Jean-Pierre Rabes, Mathilde Varret
Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 23 Year: 2020 Page: 3773-3783
Author(s): Antonina Giammanco,Angelo B. Cefalù,Davide Noto,Maurizio R. Averna
Recent Patents on PCSK9: A New Target for Treating Hypercholesterolemia
Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 3 Issue: 3 Year: 2009 Page: 201-212
Author(s): Hai Li, Haixia Li, Nick Ziegler, Rutao Cui, Jingwen Liu
Familial Hypercholesterolemia: Etiology, Diagnosis and New Treatment Options
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6220-6229
Author(s): Ioanna Gouni-Berthold, Heiner K. Berthold
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3161-3172
Author(s): Nabil G. Seidah
Proprotein Convertase Subtilisin Kexin9 (PCSK9): A Novel Target For Cholesterol Regulation
Journal: Protein & Peptide Letters
Volume: 19 Issue: 6 Year: 2012 Page: 575-585
Author(s): Ajoy Basak,Heather Palmer-Smith,Priyambada Mishra
Regulatory Effects of Peptides from the Pro and Catalytic Domains of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) on Low-Density Lipoprotein Receptor (LDL-R)
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 2168-2182
Author(s): H. Palmer-Smith, A. Basak
Clinical Biochemistry, Physiology & Genetic Disorders
Ebook: Mind Maps in Biochemistry
Volume: 1 Year: 2021
Author(s): Simmi Kharb
Doi: 10.2174/9789811477904121010017
Further LDL Cholesterol Lowering Through Targeting PCSK9 for Coronary Artery Disease
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 8 Issue: 4 Year: 2008 Page: 238-243
Author(s): Guoqing Cao, Yue-Wei Qian, Mark C. Kowala, Robert J. Konrad